Home › Executives › Aman Kumar, MD
AK

Aman Kumar, MD

Portfolio Manager - Oaktree Life Sciences Lending at Oaktree Capital Management, L.P.

Oaktree Capital Management, L.P.

View LinkedIn Profile
Experience22+ Years
LevelCXO

Career Timeline

Professional employment history
  • Oaktree Capital Management, L.P.Current
    Oct 2014–Present· 11 yrs 11 mos
    • Managing Director, Strategic CreditCurrent
      2020–Present
    • Portfolio Manager, Oaktree Life Sciences Lending
      Sep 2020–Dec 2025
    • Senior Vice President - Strategic Credit
      2018–Dec 2019
    • Vice President - Strategic Credit
      Oct 2014–2018
  • Neo Performance Materials Inc
    Oct 2017–Jun 2019· 1 yr 8 mos
    • Director
      Oct 2017–Jun 2019
  • Deutsche Bank
    Jul 2011–Sep 2014· 3 yrs 2 mos
    • Vice President - High Yield Trading
      Jul 2011–Sep 2014
  • Deutsche Bank
    Jun 2010–Sep 2010· 3 mos
    • Summer Associate
      Jun 2010–Sep 2010
  • NHS
    Aug 2004–Jul 2009· 4 yrs 11 mos
    • Otolaryngology- Head & Neck Surgery
      Aug 2004–Jul 2009

Education

MBA

Finance, Healthcare

Wharton Business School

MSc

Surgical Technology

Imperial College London

MRCS & DO-HNS

Surgery

The Royal College of Surgeons of England

MBBS

Medicine

Guy's, King's & St Thomas' School of Medicine

BSc

Anatomy & Developmental Biology

UCL

Executive Relationship Map

Reports To
Aman Kumar, MD
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer

Executive Network Preview

BizKonnect has mapped this leadership network including reporting hierarchies, peer connections, and cross-functional relationships.

Verified Contact Information
Email & Direct Dial
Org Chart & Reporting Lines
Buying Committee Insights
AI-Powered Account Mapping

Skills & Expertise

20 of 20 skills
Investment BankingOil/GasFinancial AnalysisCorporate FinanceEquity Research AnalysisFinancial ModelingValuationHealthcareEmerging MarketsGlobal HealthMetalsMedical DevicesBusiness StrategyFixed IncomeEntrepreneurshipVenture CapitalEquitiesDerivativesPharmaceutical IndustryBiotechnology